303 related articles for article (PubMed ID: 26081985)
1. AMBITION-cm: intermittent high dose AmBisome on a high dose fluconazole backbone for cryptococcal meningitis induction therapy in sub-Saharan Africa: study protocol for a randomized controlled trial.
Molefi M; Chofle AA; Molloy SF; Kalluvya S; Changalucha JM; Cainelli F; Leeme T; Lekwape N; Goldberg DW; Haverkamp M; Bisson GP; Perfect JR; Letang E; Fenner L; Meintjes G; Burton R; Makadzange T; Ndhlovu CE; Hope W; Harrison TS; Jarvis JN
Trials; 2015 Jun; 16():276. PubMed ID: 26081985
[TBL] [Abstract][Full Text] [Related]
2. AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.
Lawrence DS; Youssouf N; Molloy SF; Alanio A; Alufandika M; Boulware DR; Boyer-Chammard T; Chen T; Dromer F; Hlupeni A; Hope W; Hosseinipour MC; Kanyama C; Lortholary O; Loyse A; Meya DB; Mosepele M; Muzoora C; Mwandumba HC; Ndhlovu CE; Niessen L; Schutz C; Stott KE; Wang D; Lalloo DG; Meintjes G; Jaffar S; Harrison TS; Jarvis JN
Trials; 2018 Nov; 19(1):649. PubMed ID: 30470259
[TBL] [Abstract][Full Text] [Related]
3. Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis.
Jarvis JN; Lawrence DS; Meya DB; Kagimu E; Kasibante J; Mpoza E; Rutakingirwa MK; Ssebambulidde K; Tugume L; Rhein J; Boulware DR; Mwandumba HC; Moyo M; Mzinganjira H; Kanyama C; Hosseinipour MC; Chawinga C; Meintjes G; Schutz C; Comins K; Singh A; Muzoora C; Jjunju S; Nuwagira E; Mosepele M; Leeme T; Siamisang K; Ndhlovu CE; Hlupeni A; Mutata C; van Widenfelt E; Chen T; Wang D; Hope W; Boyer-Chammard T; Loyse A; Molloy SF; Youssouf N; Lortholary O; Lalloo DG; Jaffar S; Harrison TS;
N Engl J Med; 2022 Mar; 386(12):1109-1120. PubMed ID: 35320642
[TBL] [Abstract][Full Text] [Related]
4. Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis.
Leenders AC; Reiss P; Portegies P; Clezy K; Hop WC; Hoy J; Borleffs JC; Allworth T; Kauffmann RH; Jones P; Kroon FP; Verbrugh HA; de Marie S
AIDS; 1997 Oct; 11(12):1463-71. PubMed ID: 9342068
[TBL] [Abstract][Full Text] [Related]
5. A phase II randomized controlled trial adding oral flucytosine to high-dose fluconazole, with short-course amphotericin B, for cryptococcal meningitis.
Jackson AT; Nussbaum JC; Phulusa J; Namarika D; Chikasema M; Kanyemba C; Jarvis JN; Jaffar S; Hosseinipour MC; van der Horst C; Harrison TS
AIDS; 2012 Jul; 26(11):1363-70. PubMed ID: 22526517
[TBL] [Abstract][Full Text] [Related]
6. Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi.
Nussbaum JC; Jackson A; Namarika D; Phulusa J; Kenala J; Kanyemba C; Jarvis JN; Jaffar S; Hosseinipour MC; Kamwendo D; van der Horst CM; Harrison TS
Clin Infect Dis; 2010 Feb; 50(3):338-44. PubMed ID: 20038244
[TBL] [Abstract][Full Text] [Related]
7. Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa.
Molloy SF; Kanyama C; Heyderman RS; Loyse A; Kouanfack C; Chanda D; Mfinanga S; Temfack E; Lakhi S; Lesikari S; Chan AK; Stone N; Kalata N; Karunaharan N; Gaskell K; Peirse M; Ellis J; Chawinga C; Lontsi S; Ndong JG; Bright P; Lupiya D; Chen T; Bradley J; Adams J; van der Horst C; van Oosterhout JJ; Sini V; Mapoure YN; Mwaba P; Bicanic T; Lalloo DG; Wang D; Hosseinipour MC; Lortholary O; Jaffar S; Harrison TS;
N Engl J Med; 2018 Mar; 378(11):1004-1017. PubMed ID: 29539274
[TBL] [Abstract][Full Text] [Related]
8. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial.
Brouwer AE; Rajanuwong A; Chierakul W; Griffin GE; Larsen RA; White NJ; Harrison TS
Lancet; 2004 May; 363(9423):1764-7. PubMed ID: 15172774
[TBL] [Abstract][Full Text] [Related]
9. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.
van der Horst CM; Saag MS; Cloud GA; Hamill RJ; Graybill JR; Sobel JD; Johnson PC; Tuazon CU; Kerkering T; Moskovitz BL; Powderly WG; Dismukes WE
N Engl J Med; 1997 Jul; 337(1):15-21. PubMed ID: 9203426
[TBL] [Abstract][Full Text] [Related]
10. High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial.
Bicanic T; Wood R; Meintjes G; Rebe K; Brouwer A; Loyse A; Bekker LG; Jaffar S; Harrison T
Clin Infect Dis; 2008 Jul; 47(1):123-30. PubMed ID: 18505387
[TBL] [Abstract][Full Text] [Related]
11. Short-course High-dose Liposomal Amphotericin B for Human Immunodeficiency Virus-associated Cryptococcal Meningitis: A Phase 2 Randomized Controlled Trial.
Jarvis JN; Leeme TB; Molefi M; Chofle AA; Bidwell G; Tsholo K; Tlhako N; Mawoko N; Patel RKK; Tenforde MW; Muthoga C; Bisson GP; Kidola J; Changalucha J; Lawrence D; Jaffar S; Hope W; Molloy SLF; Harrison TS
Clin Infect Dis; 2019 Jan; 68(3):393-401. PubMed ID: 29945252
[TBL] [Abstract][Full Text] [Related]
12. Short course amphotericin B with high dose fluconazole for HIV-associated cryptococcal meningitis.
Muzoora CK; Kabanda T; Ortu G; Ssentamu J; Hearn P; Mwesigye J; Longley N; Jarvis JN; Jaffar S; Harrison TS
J Infect; 2012 Jan; 64(1):76-81. PubMed ID: 22079502
[TBL] [Abstract][Full Text] [Related]
13. Dose response effect of high-dose fluconazole for HIV-associated cryptococcal meningitis in southwestern Uganda.
Longley N; Muzoora C; Taseera K; Mwesigye J; Rwebembera J; Chakera A; Wall E; Andia I; Jaffar S; Harrison TS
Clin Infect Dis; 2008 Dec; 47(12):1556-61. PubMed ID: 18990067
[TBL] [Abstract][Full Text] [Related]
14. AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: economic evaluation protocol for a randomised controlled trial-based equivalence study.
Ponatshego PL; Lawrence DS; Youssouf N; Molloy SF; Alufandika M; Bango F; Boulware DR; Chawinga C; Dziwani E; Gondwe E; Hlupeni A; Hosseinipour MC; Kanyama C; Meya DB; Mosepele M; Muthoga C; Muzoora CK; Mwandumba H; Ndhlovu CE; Rajasingham R; Sayed S; Shamu S; Tsholo K; Tugume L; Williams D; Maheswaran H; Shiri T; Boyer-Chammard T; Loyse A; Chen T; Wang D; Lortholary O; Lalloo DG; Meintjes G; Jaffar S; Harrison TS; Jarvis JN; Niessen LW
BMJ Open; 2019 Apr; 9(4):e026288. PubMed ID: 30940760
[TBL] [Abstract][Full Text] [Related]
15. The acceptability of the AMBITION-cm treatment regimen for HIV-associated cryptococcal meningitis: Findings from a qualitative methods study of participants and researchers in Botswana and Uganda.
Lawrence DS; Ssali A; Moshashane N; Nabaggala G; Maphane L; Harrison TS; Meya DB; Jarvis JN; Seeley J
PLoS Negl Trop Dis; 2022 Oct; 16(10):e0010825. PubMed ID: 36279300
[TBL] [Abstract][Full Text] [Related]
16. CryptoDex: a randomised, double-blind, placebo-controlled phase III trial of adjunctive dexamethasone in HIV-infected adults with cryptococcal meningitis: study protocol for a randomised control trial.
Day J; Imran D; Ganiem AR; Tjahjani N; Wahyuningsih R; Adawiyah R; Dance D; Mayxay M; Newton P; Phetsouvanh R; Rattanavong S; Chan AK; Heyderman R; van Oosterhout JJ; Chierakul W; Day N; Kamali A; Kibengo F; Ruzagira E; Gray A; Lalloo DG; Beardsley J; Binh TQ; Chau TT; Chau NV; Cuc NT; Farrar J; Hien TT; Van Kinh N; Merson L; Phuong L; Tho LT; Thuy PT; Thwaites G; Wertheim H; Wolbers M
Trials; 2014 Nov; 15():441. PubMed ID: 25391338
[TBL] [Abstract][Full Text] [Related]
17. Early versus delayed antiretroviral treatment in HIV-positive people with cryptococcal meningitis.
Eshun-Wilson I; Okwen MP; Richardson M; Bicanic T
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD009012. PubMed ID: 30039850
[TBL] [Abstract][Full Text] [Related]
18. High-Dose Fluconazole Consolidation Therapy for Cryptococcal Meningitis in Sub-Saharan Africa: Much to Gain, Little to Lose.
Murphy RA; Hatlen TJ; Moosa MS
AIDS Res Hum Retroviruses; 2018 May; 34(5):399-403. PubMed ID: 29353491
[TBL] [Abstract][Full Text] [Related]
19. Triple therapy versus amphotericin B plus flucytosine for the treatment of non-HIV- and non-transplant-associated cryptococcal meningitis: retrospective cohort study.
Xu L; Liu J; Zhang Q; Li M; Liao J; Kuang W; Zhu C; Yi H; Peng F
Neurol Res; 2018 May; 40(5):398-404. PubMed ID: 29560802
[TBL] [Abstract][Full Text] [Related]
20. High dose fluconazole in salvage therapy for HIV-uninfected cryptococcal meningitis.
Zhao HZ; Wang RY; Wang X; Jiang YK; Zhou LH; Cheng JH; Huang LP; Harrison TS; Zhu LP
BMC Infect Dis; 2018 Dec; 18(1):643. PubMed ID: 30541454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
